Vir Biotechnology
VIR
P/S ratio for Vir Biotechnology (VIR)
P/S ratio as of April 2024 (TTM): 27.2
According to Vir Biotechnology 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 27.2156. At the end of 2023 the company had a P/S ratio of 34.3.
P/S ratio history for Vir Biotechnology from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 34.3 | 1507.39% |
| 2022 | 2.13 | -57.71% |
| 2021 | 5.04 | -90.06% |
| 2020 | 50.7 | -97.38% |
| 2019 | > 1000 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |